These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10465008)

  • 1. The proliferation-associated Ki-67 protein: definition in molecular terms.
    Duchrow M; Gerdes J; Schlüter C
    Cell Prolif; 1994 May; 27(5):235-42. PubMed ID: 10465008
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell proliferation-associated nuclear antigen defined by antibody Ki-67: a new kind of cell cycle-maintaining proteins.
    Duchrow M; Schlüter C; Key G; Kubbutat MH; Wohlenberg C; Flad HD; Gerdes J
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):117-21. PubMed ID: 8744726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.
    Schlüter C; Duchrow M; Wohlenberg C; Becker MH; Key G; Flad HD; Gerdes J
    J Cell Biol; 1993 Nov; 123(3):513-22. PubMed ID: 8227122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense Ki-67 cDNA transfection reverses the tumorigenicity and induces apoptosis in human breast cancer cells.
    Wang R; Luo D; Ma X; Yang W; Chen R; Liu Y; Meng L; Zhou J; Xu G; Lu YP; Wang S; Ma D
    Cancer Invest; 2008 Oct; 26(8):830-5. PubMed ID: 18798062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of cell division by pKi-67 antisense-RNA and recombinant protein.
    Duchrow M; Schmidt MHH; Zingler M; Anemüller S; Bruch HP; Broll R
    Cell Physiol Biochem; 2001; 11(6):331-8. PubMed ID: 11832658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest.
    Fujimori F; Takahashi K; Uchida C; Uchida T
    Biochem Biophys Res Commun; 1999 Nov; 265(3):658-63. PubMed ID: 10600477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of autoantibodies against Ki-67 antigen in Japanese patients with systemic autoimmune diseases.
    Muro Y; Kano T; Sugiura K; Hagiwara M
    J Autoimmun; 1997 Oct; 10(5):499-503. PubMed ID: 9376078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nucleolar protein, PAPA-1, induces growth arrest as a result of cell cycle arrest at the G1 phase.
    Kuroda TS; Maita H; Tabata T; Taira T; Kitaura H; Ariga H; Iguchi-Ariga SM
    Gene; 2004 Sep; 340(1):83-98. PubMed ID: 15556297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ki-67 protein: from the known and the unknown.
    Scholzen T; Gerdes J
    J Cell Physiol; 2000 Mar; 182(3):311-22. PubMed ID: 10653597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of mutations in the cDNA of the proliferation marker Ki-67 protein in four tumor cell lines.
    Bubán T; Schmidt MHH; Broll R; Antal-Szalmás P; Duchrow M
    Cancer Genet Cytogenet; 2004 Feb; 149(1):81-4. PubMed ID: 15104289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation-associated Ki-67 protein is a target for autoantibodies in the human autoimmune disease systemic lupus erythematosus.
    Gerlach C; Kubbutat M; Schwab U; Key G; Flad HD; Gerdes J
    Lab Invest; 1998 Jan; 78(1):129-30. PubMed ID: 9461130
    [No Abstract]   [Full Text] [Related]  

  • 12. The Ki-67 protein: fascinating forms and an unknown function.
    Endl E; Gerdes J
    Exp Cell Res; 2000 Jun; 257(2):231-7. PubMed ID: 10837136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.
    Mao Y; Wu J; Skog S; Eriksson S; Zhao Y; Zhou J; He Q
    Oncol Rep; 2005 May; 13(5):837-46. PubMed ID: 15809747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proliferation marker pKi-67 becomes masked to MIB-1 staining after expression of its tandem repeats.
    Schmidt MH; Broll R; Bruch HP; Duchrow M
    Histochem Cell Biol; 2002 Nov; 118(5):415-22. PubMed ID: 12432453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positivity of the proliferation marker Ki-67 in noncycling cells.
    van Oijen MG; Medema RH; Slootweg PJ; Rijksen G
    Am J Clin Pathol; 1998 Jul; 110(1):24-31. PubMed ID: 9661919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p150N domain of chromatin assembly factor-1 regulates Ki-67 accumulation on the mitotic perichromosomal layer.
    Matheson TD; Kaufman PD
    Mol Biol Cell; 2017 Jan; 28(1):21-29. PubMed ID: 27807046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological functions and roles in cancer of the proliferation marker Ki-67.
    Andrés-Sánchez N; Fisher D; Krasinska L
    J Cell Sci; 2022 Jun; 135(11):. PubMed ID: 35674256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle.
    MacCallum DE; Hall PA
    J Pathol; 2000 Apr; 190(5):537-44. PubMed ID: 10727979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis carinii contains a functional cell-division-cycle Cdc2 homologue.
    Thomas CF; Anders RA; Gustafson MP; Leof EB; Limper AH
    Am J Respir Cell Mol Biol; 1998 Mar; 18(3):297-306. PubMed ID: 9490647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferation evaluation by measuring Ki67 in breast neoplasms].
    Vincent-Salomon A
    Ann Pathol; 2011 Nov; 31(5 Suppl):S57-9. PubMed ID: 22054462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.